With recent acquisitions, Glaukos now has multiple products in development that expand its reach outside of the glaucoma space and into more comprehensive ophthalmology, CEO Tom Burns said at the J.P. Morgan Healthcare Conference.
“Our mission at Glaukos from our inception has been to transform glaucoma therapy, but our vision has always been broader and more inspirational,” Burns said. “Over the last several years, we’ve been building the foundation to create the next formidable comprehensive eye care company in ophthalmology.”
While Glaukos’ glaucoma
Uncategorized